| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.29 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.09 |